• Policy
• DUR check for more than 28 days of Zolpidem combined Rx
• by Lee, Hye-Kyung Sep 29, 2021 05:54am

• Policy
• Delstrigo listed at ₩19,491 … Zejula’s price cut 6%
• by Kim, Jung-Ju Sep 29, 2021 05:53am

• Policy
• Domestic venture introduces new imported breast cancer drug
• by Lee, Tak-Sun Sep 28, 2021 05:54am

• Policy
• Will Rinvoq be approved for atopic dermatitis?
• by Lee, Tak-Sun Sep 28, 2021 05:54am

• Policy
• Pfizer vaccine for 1.67 million doses, about to be discarded
• by Lee, Jeong-Hwan Sep 28, 2021 05:53am

• Policy
• 129 drug price reduction starting in October
• by Kim, Jung-Ju Sep 28, 2021 05:53am

• Policy
• Is the third Avastin biosimilar coming out?
• by Lee, Tak-Sun Sep 27, 2021 05:51am

• Policy
• The per capita GDP reference standard was deleted from ICER
• by Lee, Hye-Kyung Sep 27, 2021 05:51am

• Policy
• Reimbursed generics pour in with Xarelto's patent expiry
• by Kim, Jung-Ju Sep 24, 2021 05:57am

• Policy
• Lynparza RSA renewed, adds reimbursement for ovarian cancer
• by Lee, Hye-Kyung Sep 24, 2021 05:56am